Insider Transactions Reported by 21 Insiders of Elicio Therapeutics, Inc.

Symbol
ELTX on Nasdaq
Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Elicio Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yekaterina Chudnovsky Director, 10%+ Owner $39,452,192 03 Jun 2025
EISA-ABC LLC 10%+ Owner $15,925,082 31 Aug 2021
Itzhak Goldberg Director $9,807,199 01 Jul 2022
Robert Connelly CEO, President and Director, Director $959,737 02 Feb 2026
Christopher Haqq Executive Vice President, Head of R&D and Chief Medical Officer $456,752 02 Feb 2026
Jay R. Venkatesan Director $251,306 19 May 2025
Preetam Shah Chief Strategy and Financial Officer $191,040 02 Feb 2026
Peter DeMuth Chief Scientific Officer $171,482 02 Feb 2026
Victor F. Ganzi Director $87,150 09 Jun 2022
Gilbert S. Omenn Director $87,150 09 Jun 2022
John F. Neylan Executive Vice President, Chief Medical Officer and Head of Research 02 Mar 2022
Gregory S. Curhan Chief Financial Officer 02 Mar 2022
Jennifer J. Rhodes Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary 02 Mar 2022
Annette Matthies Chief Business Officer 01 Jun 2023
Assaf Segal Director 01 Jun 2023
Karen J. Wilson Director 19 May 2025
Allen R. Nissenson Director 19 May 2025
Julian Adams Director 19 May 2025
Carol Gail Ashe Director 19 May 2025
Robert R. Ruffolo Director 19 May 2025
Brian Piekos Chief Financial Officer 01 Feb 2024

Recent Insider Transactions by Companies or Individuals for Elicio Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Robert Connelly ELTX Common Stock Award 156.7% 73,600 120,570 02 Feb 2026 Direct
Robert Connelly ELTX Stock Option (Right to Buy) Award 147,200 147,200 02 Feb 2026 Direct
Preetam Shah ELTX Common Stock Award 24,000 24,000 02 Feb 2026 Direct
Preetam Shah ELTX Stock Option (Right to Buy) Award 47,900 47,900 02 Feb 2026 Direct
Peter DeMuth ELTX Common Stock Award 2799.5% 20,800 21,543 02 Feb 2026 Direct
Peter DeMuth ELTX Stock Option (Right to Buy) Award 41,600 41,600 02 Feb 2026 Direct
Christopher Haqq ELTX Common Stock Award 79.4% 25,400 57,381 02 Feb 2026 Direct
Christopher Haqq ELTX Stock Option (Right to Buy) Award 50,900 50,900 02 Feb 2026 Direct
Peter DeMuth ELTX Common Stock Options Exercise 95% 362 743 09 Dec 2025 Direct
Peter DeMuth ELTX Stock Option (Right to Buy) Options Exercise -100% -362 0 09 Dec 2025 Direct
Yekaterina Chudnovsky ELTX Warrant (right to buy) Award 103,225 103,225 03 Jun 2025 Held by GKCC, LLC
Carol Gail Ashe ELTX Stock Option (Right to Buy) Award 7,900 7,900 19 May 2025 Direct
Allen Nissenson ELTX Stock Option (Right to Buy) Award 7,900 7,900 19 May 2025 Direct
Jay Venkatesan ELTX Stock Option (Right to Buy) Award 7,900 7,900 19 May 2025 Direct
Julian Adams ELTX Stock Option (Right to Buy) Award 7,900 7,900 19 May 2025 Direct
Karen J. Wilson ELTX Stock Option (Right to Buy) Award 7,900 7,900 19 May 2025 Direct
Robert R. Ruffolo ELTX Stock Option (Right to Buy) Award 7,900 7,900 19 May 2025 Direct
Yekaterina Chudnovsky ELTX Stock Option (Right to Buy) Award 7,900 7,900 19 May 2025 Direct
Preetam Shah ELTX Stock Option (Right to Buy) Award 191,624 191,624 15 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.